ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO 2022 on a Phase II S1800A Trial: Ramucirumab + Pembrolizumab Improves OS in Advanced NSCLC
By
ecancer
FEATURING
Roy Herbst
By
ecancer
FEATURING
Roy Herbst
Login to view comments.
Click here to Login
